Differences in systemic adaptive immunity contribute to the 'frequent exacerbator' COPD phenotype

被引:24
|
作者
Geerdink, Jasper X. [1 ,2 ]
Simons, Sami O. [1 ]
Pike, Rebecca [3 ]
Stauss, Hans J. [3 ]
Heijdra, Yvonne F. [1 ]
Hurst, John R. [2 ]
机构
[1] Radboud Univ Nijmegen, Dept Resp Med, Med Ctr, Nijmegen, Netherlands
[2] UCL, UCL Resp, London, England
[3] UCL, Inst Immun & Transplantat, London, England
来源
RESPIRATORY RESEARCH | 2016年 / 17卷
关键词
COPD; COPD exacerbation; Respiratory immunology; Flow cytometry; Adaptive immunity; OBSTRUCTIVE PULMONARY-DISEASE; EPSTEIN-BARR-VIRUS; T-CELL RESPONSES; INFECTION; PERSISTENCE; MEMORY; HETEROGENEITY; DYSFUNCTION; SEVERITY; SYMPTOMS;
D O I
10.1186/s12931-016-0456-y
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Some COPD patients are more susceptible to exacerbations than others. Mechanisms underlying these differences in susceptibility are not well understood. We hypothesized that altered cell mediated immune responses may underlie a propensity to suffer from frequent exacerbations in COPD. Methods: Peripheral blood mononuclear cells (PBMCs) were obtained from 24 stable COPD patients, eight frequent exacerbators (>= 3 diary-card exacerbations/year) and 16 infrequent exacerbators (< 3 diary-card exacerbations/year). Detailed multi-parameter flow cytometry was used to study differences in innate and adaptive systemic immune function between frequent and infrequently exacerbating COPD patients. Results: The 24 COPD patients had a mean (SD) age of 76.3 (9.4) years and FEV1 1.43 (0.60) L, 53.3 (18.3)% predicted. PBMCs of frequent exacerbators (FE) contained lower frequencies of CD4+ T central memory cells (CD4+ Tcm) compared to infrequent exacerbators (IE) (FE = 18.7 %; IE = 23.9 %; p = 0.035). This observation was also apparent in absolute numbers of CD4+ Tcm cells (FE = 0.17 x 10(Lambda)6/mL; IE = 0.25 x 10(Lambda)6/mL; p = 0.035). PBMCs of FE contained a lower frequency of CD8+ T effector memory cells expressing HLA-DR (Human Leukocyte Antigen - D Related) compared to IE COPD patients (FE = 22.7 %; IE = 31.5 %; p = 0.007). Conclusion: Differences in the adaptive systemic immune system might associate with exacerbation susceptibility in the `frequent exacerbator' COPD phenotype. These differences include fewer CD4+ T central memory cells and CD8+ T effector memory cells.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] The frequent exacerbator phenotype in bronchiectasis: predictors and particularities
    Ben Saad, Ahmed
    Mhamed, Saousen Cheikh
    Trigui, Ghassen
    Fahem, Nesrine
    Migaou, Asma
    Joobeur, Samah
    Rouatbi, Naceur
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [32] Unravelling the "frequent exacerbator" phenotype in cystic fibrosis
    Cohen, Raya
    Shteinberg, Michal
    EUROPEAN RESPIRATORY JOURNAL, 2024, 63 (02)
  • [33] The frequent exacerbator phenotype in asthma: a clinical characterization
    Sprio, Andrea
    Carriero, Vitina
    Levra, Stefano
    Botto, Carlotta
    Bertolini, Francesca
    Ricciardolo, Fabio Luigi Massimo
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [34] Do inhaled corticosteroids reduce the frequent exacerbator phenotype in COPD - A little help by a multicenter survey
    Klopf, Dieter
    Rumpf, Johannes
    Maier-Stocker, Peter
    Thomas, Kai
    Koehl, Christoph
    Sommer, Claudia
    Berg, Peter
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [35] The usefulness of soluble receptor for advanced glycation end-products in the identification of COPD frequent exacerbator phenotype
    Milkowska-Dymanowska, Joanna
    Bialas, Adam J.
    Szewczyk, Karolina
    Kurmanowska, Zofia
    Gorski, Pawel
    Piotrowski, Wojciech J.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018, 13 : 3879 - 3884
  • [36] Influence of pulmonary rehabilitation in patients with COPD exacerbator phenotype
    Bohn Junior, Ivo
    da Costa, Cassia Cinara
    de Souza, Rafael Machado
    dos Santos, Alvaro Huber
    Zimermann Teixeira, Paulo Jose
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2020, 46 (06)
  • [37] High risk of subclinical atherosclerosis in COPD exacerbator phenotype
    Domenech, Adolfo
    Munoz-Montiel, Ana
    Garcia-Casares, Natalia
    Rioja, Jose
    Ruiz-Esteban, Pedro
    Gutierrez-Castano, Patricia
    Prunera Pardell, Maria Jesus
    Olveira, Casilda
    Valdivielso, Pedro
    Angel Sanchez-Chaparro, Miguel
    RESPIRATORY MEDICINE, 2018, 141 : 165 - 171
  • [38] COPD Exacerbator Phenotype is Inversely Associated with Current Smoking But Not with Haptoglobin Phenotype
    Tal, Sagee
    Adir, Yochai
    Stein, Nili
    Shalom, Hadar
    Lache, Orit
    Levy, Andrew
    Shteinberg, Michal
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2019, 21 (01): : 19 - 23
  • [39] Increased plasma osteopontin in frequent exacerbator and acute exacerbation of COPD
    Lee, Seung Jun
    Kim, Sung Hwan
    Kim, Wanchul
    Lim, Sujin
    Lee, Seung Hun
    Kim, Yu Eun
    Cho, Yu Ji
    Jeong, Yi Yeong
    Kim, Ho Cheol
    Lee, Jong Deog
    Hwang, Young Sil
    CLINICAL RESPIRATORY JOURNAL, 2014, 8 (03): : 305 - 311
  • [40] The effect on mortality of adding inhaled corticosteroids to long-acting bronchodilators for COPD: A focus on the frequent exacerbator phenotype
    Di Martino, Mirko
    Agabiti, Nera
    Cascini, Silvia
    Kirchmayer, Ursula
    Belleudi, Valeria
    Fusco, Danilo
    Pinnarelli, Luigi
    Bauleo, Lisa
    Voci, Claudio
    Pistelli, Riccardo
    Davoli, Marina
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46